Current & Recent Highlights
Innovisory Group helped a growing overseas SaaS company take its biggest growth leap by managing the client's entry into its biggest market yet: North America.
Galatea (www.teamgalatea.com) is an Israel-based SaaS company launched five years ago by the business and investment team behind several successful software and IT ventures throughout Europe, Asia, Australia and other regions worldwide. Galatea provides cloud-based maintenance management solutions to commercial, military and recreational clients in the maritime industry.
Galatea contacted us when they looked to expand their business significantly with a major entrance into North America, the world's largest maritime market. To optimize our efforts and accelerate our time to market, Innovisory Group placed an Interim President into Galatea for this engagement.
This close collaborative approach enabled us to more effectively shape the business model for this new market landscape, recruit key employees, understand the organization's strengths and weaknesses—both real and perceived within the market—craft detailed financial models and metrics, and even manage set-up of the company's legal, financial and operational processes here in North America. Other key deliverables include:
BRAND:
-
Re-branding, with new name for flagship product series
-
New logo and visual identity
PRODUCT:
-
Product (re)definition and new service model strategy
-
Product roadmaps, feature/capability prioritization
-
Pilot testing program
GO-TO-MARKET:
-
Key market assumptions, market opportunity analysis
-
Pricing and financial scenario modeling
-
Key metrics and critical success benchmarks
-
Onboarding process and technology strategy
SALES & MARKETING:
-
Key value messaging, selling statements
-
Sales playbooks, lead nurturing roadmaps
-
New website content, digital marketing
-
Sales and marketing collateral, content library
Within the first quarter after launching in North America, Galatea has already surpassed the leading solution provider and continues to grow its business worldwide.
Halo-Bio RNAi Pharamceuticals (www.halo-bio.com) is four-year-old biotechnology firm with a breakthrough patented technology for applications in biopharma, gene therapy and disease research. The company engaged Innovisory Group when it looked to commercialize its technology across several different sectors, as well as to raise its presence and profile in the market — in particular, among investment communities and key market influencers.
We began with broad segment surveys to quickly identify, measure and prioritize "low-hanging fruit" opportunities, then designed and conducted targeted audits to further pinpoint where best to rationalize and invest for growth in both the near and long term, based on a variety of key factors: market and competitive trends, strategic partnership opportunities, emerging technologies across the IP landscape, recent investment trends and more.
From there came a product roadmap designed to minimize financial risk and optimize organic growth and ROI within an accelerated timeline. We worked closely with the leadership and sales team through initial pilot programs to help evaluate key pivots and further refine product strategy and segment roadmaps.
Now we are working with the client to take its technology to a broader market and a bigger audience of investors, partners and other stakeholders—creating messaging, sales strategies and materials, presentations, white papers, media programs and more. Today Halo-Bio is poised to enter multi-billion-dollar markets with solutions that could have a profound and lasting impact throughout the industry.
Innovisory Group helped an emerging biotech innovator chart the market landscape, commercialize its technology, and tell its story to investors, clients, strategic partners and other audiences.
Trillium Ag (www.trilliumag.com) is an emerging bio-agricultural company based in Seattle, WA. Trillium is working with partners worldwide to develop its proprietary technology into a new class of specialized biologicals that can dramatically improve crop health and yield. Innovisory Group has been working with Trillium to help the company bring its innovative approach to sustainable bio-agriculture to market — and, along the way, to the attention of investors, media, strategic partners and others.
Trillium's leading edge technology and strong IP position has opened up a broad field of product opportunities, with different potential business models and commercialization strategies for each. Innovisory is helping the company to measure these various pathways, both quantitatively and qualitatively, and evaluate each against a variety of dynamic criteria in order to i) accelerate short-term growth, ii) optimize its own financial leverage from one opportunity to the next, and iii) maximize long-term returns.
Based on these analyses, we are working with executive leaders to develop business plans, create financial models and scenarios, and define targeted commercialization strategies and the programs that carry them forward.
We are also helping Trillium tell its unique and exciting story to the world, creating messaging and media relations programs, web and social media content, white papers, presentations and a growing variety of materials that will move our client to the forefront of its rapidly-evolving marketspace.
Innovisory Group is helping a new bio-ag company grab the attention of investors, partners, media and markets worldwide about its remarkable solutions to difficult, costly problems plaguing farmers worldwide.
